SeNostic
Latest round
- Seed
Last raised
- Jan 2016
Total raised
- Undisclosed
Investors
- 1
About SeNostic
SeNostic develops diagnostic solutions for neurodegenerative diseases, focusing on Alzheimer's and Parkinson's disease.Founded in 2014 and headquartered in Braunschweig, Germany, SeNostic specializes in diagnostic solutions for neurodegenerative diseases.SeNostic specializes in the development of diagnostic solutions for neurodegenerative diseases, particularly focusing on conditions such as Alzheimer’s and Parkinson’s disease. The company's core offerings include in-vitro diagnostics (Dx) for clinical trials, recombinant proteins for research purposes, and tailored services aimed at drug research. These products are designed to enhance the understanding and treatment of neurodegenerative conditions, providing critical data that can facilitate more effective clinical interventions. The primary clientele includes pharmaceutical companies and research institutions involved in drug development, with a focus on markets across North America, Europe, and Asia.SeNostic's revenue model is based on a combination of direct partnerships and B2B transactions with pharmaceutical companies and clinical research organizations. These transactions typically involve the provision of specialized diagnostic tools and recombinant proteins, which are integral to drug research and development processes. Clients engage with SeNostic through contractual agreements that outline specific service levels and product deliveries, ensuring tailored solutions that meet their research needs. The pricing structure for these services is designed to reflect the complexity and value of the diagnostic insights provided, with various plans available depending on the scope of research and number of services utilized. The company is targeting expansion into North American and Asian markets by 2025, intending to increase its product offerings and client base. Upcoming products are expected to be launched within the next 18 months, focusing on innovative diagnostics that cater to the evolving needs of the pharmaceutical sector.
Who invested in SeNostic
1 investor across 1 round
See all investors in SeNostic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 25, 2016
Amount
Undisclosed
Investors
Questions about SeNostic
Who invested in SeNostic?
SeNostic has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SeNostic raised?
SeNostic has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SeNostic last raise money?
SeNostic's most recent round on record is a Seed, in Jan 2016.
What does SeNostic do?
SeNostic develops diagnostic solutions for neurodegenerative diseases, focusing on Alzheimer's and Parkinson's disease.
Where is SeNostic headquartered?
SeNostic is headquartered in Braunschweig, Germany.
Which VCs invest in companies like SeNostic?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at SeNostic's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like SeNostic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.